The abstract is read at the publisher; the summary is JClub's.
In 11,817 post–acute coronary syndrome patients, hsCRP independently predicted MACE, and combined hsCRP–IL-6 stratification linked elevated levels to higher MACE and death risk.
- Why it matters: After ACS, hsCRP and IL-6 are both linked to adverse outcomes, but it was unclear whether their prognostic signals are independent and complementary.
- What they did: Using proportional hazards models in ODYSSEY OUTCOMES post hoc analyses, log-transformed hsCRP and IL-6 were related to MACE and all-cause death, adjusting for the other biomarker and clinical covariates.
- The result: hsCRP and IL-6 showed moderate correlation (r = 0.52); hsCRP remained an independent MACE predictor, while both markers predicted death, and elevated risk was seen when both were high.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.